NAD+ 1g & Retatrutide - A UK Report
The emerging landscape of metabolic wellness in the UK is seeing heightened interest in the combination of high-dose NAD+ supplementation – often at 1 gram – and the novel GLP-1 receptor agonist Retatrutide (or its similar Tirzepatide). Researchers are observing potential effects regarding glucos